NASDAQ

ProKidney Corp. - Class A Ordinary Shares (PROK)

♥ 660 Thanks from members

Live price chart, market sentiment, and community perspectives for ProKidney Corp. (NASDAQ: PROK).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Dr. Anthony AtalaFounder: Vascular Biogenics researchersLeadership: Tim Ting (CEO)Leadership: David Reuter (CFO)Holder: Fidelity Management and ResearchHolder: The Vanguard GroupWILP (Algenpantucel-L)Cell Therapy Platform for Renal Failure#PROK stock#ProKidney#cell therapy#kidney disease treatment#NASDAQ PROK